Current Vaccine Shortages & Delays
Last Updated July 6, 2016
This web page contains the latest national information about vaccine supplies and provides guidance to healthcare providers who are facing vaccine shortages or delays.
*Note: Only those vaccines included on the recommended childhood and adolescent immunization schedule are included in this update.
Vaccines are listed in order used for the Childhood and Adolescent Immunization Schedule.
National Vaccine Supply Shortages
|Temporary Change From Routine Recommendation
|Diphtheria, Tetanus, & Pertussis (DTaP and Tdap)
|See note 2
|See current information about Pentacel[4 pages] Dec 2015
|Haemophilus influenzae type B (Hib)
|Pneumococcal Conjugated (PCV)
|Pneumococcal Polysaccharide (PPV)
|Inactivated Polio (IPV)
|Measles, Mumps, & Rubella (MMR)
|See note 1
|See Q&As about monovalent M-M-R vaccines Oct 2009
|See current information about influenza
|Conjugated Meningococcal (MCV4)
|Human Papillomavirus (HPV)
Note1: Based on input from the ACIP, professional societies, scientific leaders, and customers on October 26, 2009 Merck announced the company has decided not to resume production of ATTENUVAX® (Measles Virus Vaccine Live), MUMPSVAX® (Mumps Virus Vaccine Live), and MERUVAX®II (Rubella Virus Vaccine Live). This science-based decision will support vaccination of the largest group of appropriate individuals. Updated Jan 2010
Note2: Sanofi Pasteur is experiencing a manufacturing delay with Pentacel (DTaP-IPV/Hib) vaccine, which is anticipated to result in constrained supplies that will extend into the second half of 2016. However, Sanofi Pasteur has sufficient supplies of the relevant single antigen vaccines (DAPTACEL, ActHIB, and IPOL) to address the anticipated gap in Pentacel supply. Updated Jul 2016Top of Page
In the United States shortages of many vaccines in the recommended childhood immunization schedule occurred in the past. Some of these shortages were widespread while others were localized. Reasons for these shortages were multi-factorial and included companies leaving the vaccine market, manufacturing or production problems, and insufficient stockpiles. Consequently, some shortages were only specific to one manufacturer.
Shortages of several of these vaccines necessitated temporary changes in recommendations for their use. During that period, summary information about the shortages including projected duration and recommendations for temporary changes in the childhood immunization schedule were provided.
- Questions including those dealing with changes in child care and school requirements necessitated by vaccine supply problems when they occur can be answered by State Health Department immunization programs.
- General immunization questions can be answered by
The CDC Contact Center at 1-800-CDC-INFO
(1-800-232-4636) English and Español
This vaccines shortages page on CDC's Vaccines & Immunizations site is updated as needed to provide public information on vaccine shortages and/or delays.
The FDA's web page on Biological Product Shortages provides additional information regarding regulatory issues related to vaccine supply.Top of Page
Those acronyms and abbrevations not already spelled out above include
- AAFP - American Academy of Family Physicians
- AAP - American Academy of Pediatrics
- ACIP - Advisory Committee on Immunization Practices
- CDC - Centers for Disease Control and Prevention
- FDA - Food and Drug Administration
- GAO - United States General Accounting Office
- GSK - GlaxoSmithKline
- MMRV - Measles, Mumps, Rubella, and Varicella combination vaccine
- MMWR - Morbidity and Mortality Weekly Report
- NCIRD - National Center for Immunization and Respiratory Diseases
- TTY - teletypewriter
- Other acronyms
- Status of Recently Submitted, Licensed, and Recommended Vaccines & Biologics
Red Book® Online
- Influenza Vaccination Recommendations
- Childhood & Adolescent Immunization Schedules
- Adult Immunization Schedule
- Standards for Immunization Practices for children & adolescents and adults[7 pages]